Atlas Trials

Telios Pharma, Inc.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Telios Pharma, Inc.

RecordFirmDate
Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis (NCT07220408)Telios Pharma, Inc.2025-10-23
Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis (NCT06686472)Telios Pharma, Inc.2024-10-03
A Study Of TL-925 For The Treatment of AC (NCT06293820)Telios Pharma, Inc.2024-04-11
A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease (NCT06225973)Telios Pharma, Inc.2024-02-06
A Study of TL-925 for the Treatment of Allergic Conjunctivitis (NCT06153342)Telios Pharma, Inc.2023-11-01
A Study of TL-925 as a Treatment for Dry Eye Disease (NCT05745064)Telios Pharma, Inc.2023-02-27
Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib (NCT05280509)Telios Pharma, Inc.2022-06-09
TL-895 and KRT-232 Study in Acute Myeloid Leukemia (NCT04669067)Telios Pharma, Inc.2021-03-31
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis (NCT04655118)Telios Pharma, Inc.2020-10-22
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer (NCT04419623)Telios Pharma, Inc.2020-07-09

Track Telios Pharma, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.